Is it time to reconsider the BCLC/AASLD therapeutic flow-chart? - Wikidata - wikimedia - TriplyDB

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

http://www.wikidata.org/entity/Q37795703

about

Alcohol and hepatocellular carcinoma: a review and a point of view Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.The best strategy for HCC patients at each BCLC stage: a network meta-analysis of observational studies.New idea for treatment strategies for Barcelona Clinic Liver Cancer stages based on a network meta-analysis.Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.Robotic liver surgery is the optimal approach as bridge to transplantation.Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma.Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.Two Nomograms to Select Hepatocellular Carcinoma Patients with Macroscopic Vascular Invasion for Hepatic Resection

P2860

Q26860623-B66F6A59-2E63-48F0-8B1B-6C1E98C27CC5 Q35553137-1EC6000B-7B8E-4591-9689-E5ADD4B90440 Q35626764-E67DC62A-CBA7-47B6-B00D-E683CED35940 Q36016881-EEF84714-1B79-46DF-B29D-0A0D069DC0D5 Q36151948-06BE8186-0E82-4AF6-87CD-843675CEA33A Q36252941-B40E21B2-EF62-4BEB-8321-A2E3CF6604A5 Q36374070-1B953399-5BAF-469B-83F0-0CD0EAE035E2 Q36429818-DB335CA5-B422-4059-B6C1-903EB74CF09D Q37096406-41A37801-E3AA-4D44-83EB-82025972249C Q37725279-DCC559A1-2767-4BE0-A6D1-4E379C0E2115 Q40327672-A0283118-9138-448C-94A0-6E7A5980D1AC Q42129377-119368AA-A233-4CEA-A6F5-9CF919BA4490 Q48123781-4A4EF364-F115-4A79-837B-76FCF66FDA92 Q57116779-115E188A-6D4A-47E4-BE61-44723C61BC64

P2860

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

http://www.wikidata.org/entity/Q37795703

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@en

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@nl

type

label

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@en

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@nl

prefLabel

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@en

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@nl

P1433

Q37795703-1DF2713F-12B7-436C-94BD-A2DCFCF071F2

P1476

Q37795703-F22D6264-3E18-4C63-841D-FDADBF1FDB5D

P2093

Q37795703-082BA21F-3E8A-467A-8692-1FBE8AD28227

Q37795703-85ABBEA7-12ED-4FDA-B97E-177465B8C847

Q37795703-8D89FFDC-A080-4093-B7E7-CF88709BFC37

Q37795703-DCA21A40-0C72-4FD5-AA6D-F920DD38A332

Q37795703-F71B1755-BE4F-455B-80F4-7C19B04ECC17

P2860

Q37795703-026CE988-2D56-40F0-8843-63E706084292

Q37795703-047455AE-9FD9-4C83-8349-ABBE34D61FCE

Q37795703-04918914-4423-43E2-B788-73F30994F6B9

Q37795703-072020A1-4875-4FD0-951B-AA3369EABC40

Q37795703-085A52D7-CB83-4E26-9E7D-1EAF1273B157

Q37795703-0CA29AD0-D589-4E68-9EC8-8745A00A09AC

Q37795703-0CEE7CB8-C8E9-4715-B8F8-DD9553CEFBA0

Q37795703-156D4503-5933-4C3F-9F0C-61A146EF1B60

Q37795703-1B4F2562-805A-46B8-9B4C-00AA53E5893E

Q37795703-24F0CCB3-D052-4F1F-AD00-55FFD8F391B9

P304

Q37795703-AAEC2828-65E4-4E30-9C79-E36DBF059B9D

P31

Q37795703-F5D84A7B-71E4-43C3-A87E-9A8E6B39AD9C

P356

Q37795703-AD1FEF29-1F3E-4C09-9D0B-A23D5B717054

P433

Q37795703-9A7AA402-9AF3-4BA8-B57E-F1EF0C8D3B92

P478

Q37795703-C8E77DF5-BC2E-4B89-AE34-B4BB52438848

P577

Q37795703-7A6EAB7D-B089-42B2-8E6D-08EBDBACF181

P698

Q37795703-1D4FCF2D-922B-46BD-A14C-4B983F0C4F67

P356

P1433

Journal of Surgical Oncology

P1476

Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?

@en

P2093

Carlo Carnaghi

http://www.w3.org/2001/XMLSchema#string

Giorgio Brambilla

http://www.w3.org/2001/XMLSchema#string

Guido Torzilli

http://www.w3.org/2001/XMLSchema#string

Maurizio A Tommasini

http://www.w3.org/2001/XMLSchema#string

Tito Livraghi

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenes and Cancer

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

P304

868-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.21733

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20886553

http://www.w3.org/2001/XMLSchema#string